TFF Pharmaceuticals, Inc.
NASDAQ:TFFP
1.63 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 5.478 | 16.612 | 33.795 | 35.301 | 28.095 | 10.262 | 0 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 5.478 | 16.612 | 33.795 | 35.301 | 28.095 | 10.262 | 0 |
Net Receivables
| 0.434 | 0.187 | 2.595 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.678 | 2.226 | 2.448 | 2.258 | 1.092 | 0.012 | 0 |
Total Current Assets
| 7.59 | 19.025 | 38.838 | 37.559 | 29.187 | 10.274 | 0 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 2.119 | 3.274 | 1.86 | 1.103 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.318 | 1.821 | 0 | 0 | 0 | 0.128 | 0 |
Total Non-Current Assets
| 4.437 | 5.095 | 1.86 | 1.103 | 0 | 0.128 | 0 |
Total Assets
| 12.027 | 24.12 | 40.698 | 38.662 | 29.187 | 10.402 | 0 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 0.958 | 0.92 | 1.494 | 1.298 | 0.411 | 0.429 | 0.002 |
Short Term Debt
| 0.084 | 0.081 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0.101 | 0.126 | 0.05 | 0.024 | 0 | 0 | 0 |
Other Current Liabilities
| 1.286 | 0.004 | 0.417 | 0 | 0 | 0.728 | 0 |
Total Current Liabilities
| 2.429 | 1.131 | 1.961 | 1.322 | 0.411 | 1.157 | 0.002 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0.032 | 0.11 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 0 | 0.417 | 0 | 1.132 | 0 | 0 |
Total Non-Current Liabilities
| 0.032 | 0.11 | 0.417 | 0 | 1.132 | 0.429 | 0.002 |
Total Liabilities
| 2.46 | 1.241 | 1.961 | 1.322 | 1.543 | 1.157 | 0.002 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 29.187 | 12.486 | 0 |
Common Stock
| 0.002 | 0.036 | 0.025 | 0.023 | 0.018 | 0.004 | 0 |
Retained Earnings
| -118.332 | -97.088 | -65.318 | -34.28 | -15.712 | -3.842 | -0.002 |
Accumulated Other Comprehensive Income/Loss
| -0.148 | -0.139 | -0.049 | -0.052 | -29.187 | -12.486 | 0 |
Other Total Stockholders Equity
| 128.045 | 120.071 | 104.079 | 71.648 | 43.339 | 13.083 | 0 |
Total Shareholders Equity
| 9.567 | 22.879 | 38.737 | 37.34 | 27.645 | 9.245 | -0.002 |
Total Equity
| 9.567 | 22.879 | 38.737 | 37.34 | 27.645 | 9.245 | -0.002 |
Total Liabilities & Shareholders Equity
| 12.027 | 24.12 | 40.698 | 38.662 | 29.187 | 10.402 | 0 |